These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3763616)

  • 1. Pharmacokinetics of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3- quinoline- carboxylic acid (CFPQ) in turkeys.
    Conzelman GM; McMillan RA; Baggot JD
    Proc West Pharmacol Soc; 1986; 29():321-3. PubMed ID: 3763616
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-q uinoline- carboxylic acid (BAY Vp 2674) in chickens.
    Conzelman GM; Babish JG; Davidson JN; McMillan RA; Copeland DD
    Proc West Pharmacol Soc; 1987; 30():393-5. PubMed ID: 3628311
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to the quinolones and fluoroquinolones for the development of generic and specific immunoassays for detection of these residues in animal products.
    Bucknall S; Silverlight J; Coldham N; Thorne L; Jackman R
    Food Addit Contam; 2003 Mar; 20(3):221-8. PubMed ID: 12623645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Syntheses of 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[(4-P-nitrobenzol)-1- piperazinyl] quinoline-3-carboxylic acid and its analogues].
    Chen HC; Guo YC; Lu DR
    Yao Xue Xue Bao; 1991; 26(4):299-302. PubMed ID: 1659771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of 6-chloro-1-cyclopropyl-7-(1-piperazinyl)-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid and analogues].
    Li XH; Tian ZM; Miao H; Yu LX; Guo HY
    Yao Xue Xue Bao; 1997 Nov; 32(11):844-51. PubMed ID: 11596203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and antibacterial action of 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-aroylthiocarbamoyl-1-piperaziny l)-3-quinoline carboxylic acids].
    Jia XS; Wang YL; He FS; Shan YF; Li YF; Wang Y
    Yao Xue Xue Bao; 1993; 28(6):477-80. PubMed ID: 8249608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and antibacterial activity of 5-amino-6, 8-difluoro-1-(5-fluoro-2-pyridyl)-7-(3-methyl-1-piperazinyl)-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues].
    Liu JY; Wei YG; Guo HY
    Yao Xue Xue Bao; 2001 Jun; 36(6):419-22. PubMed ID: 12585124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro monitoring of ciprofloxacin antacids interactions by UV & HPLC.
    Sultana N; Arayne MS; Hussain F
    Pak J Pharm Sci; 2005 Oct; 18(4):23-31. PubMed ID: 16380354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1H-pyrrol-1-yl)-quinoline-3-carb oxylic acid, a new fluorinated compounds of oxacin family with high broad-spectrum antibacterial activities.
    Stefancich G; Artico M; Corelli F; Massa S; Panico S; Simonetti N
    Farmaco Sci; 1985 Apr; 40(4):237-48. PubMed ID: 3926533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of ciprofloxacin into parotid gland tissue and parotid saliva.
    Maier H; Sziegoleit A; Merck S
    Arzneimittelforschung; 1987 Jul; 37(7):797-8. PubMed ID: 3675673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of enrofloxacin in turkeys.
    Dimitrova DJ; Lashev LD; Yanev SG; Pandova B
    Res Vet Sci; 2007 Jun; 82(3):392-7. PubMed ID: 17107697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Researches on antibacterial and antifungal agents. II - Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)quinoline-3-carboxylic acid, a novel highly active, broad-spectrum antibacterial agent related to piromidic acid.
    Corelli F; Massa S; Stefancich G; Artico M; Panico S; Simonetti N
    Farmaco Sci; 1984 Feb; 39(2):95-109. PubMed ID: 6425079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ciprofloxacin on epinephrine and collagen-induced thrombocyte aggregation in vitro].
    Reuter HD; Thiele S
    Arzneimittelforschung; 1986 Jul; 36(7):1144-7. PubMed ID: 3768086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives.
    Sriram D; Yogeeswari P; Basha JS; Radha DR; Nagaraja V
    Bioorg Med Chem; 2005 Oct; 13(20):5774-8. PubMed ID: 16039859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fungus Pestalotiopsis guepini as a model for biotransformation of ciprofloxacin and norfloxacin.
    Parshikov IA; Heinze TM; Moody JD; Freeman JP; Williams AJ; Sutherland JB
    Appl Microbiol Biotechnol; 2001 Aug; 56(3-4):474-7. PubMed ID: 11549022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with ciprofloxacin in vitro and in vivo.
    Giamarellou H; Efstratiou A; Tsagarakis J; Petrikkos G; Daikos GK
    Arzneimittelforschung; 1984; 34(12):1775-8. PubMed ID: 6442151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and structural elucidation of urinary metabolites of ciprofloxacin.
    Gau W; Kurz J; Petersen U; Ploschke HJ; Wuensche C
    Arzneimittelforschung; 1986 Oct; 36(10):1545-9. PubMed ID: 3814216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on pyridonecarboxylic acids as antibacterial agents. XIV. Synthesis and structure-activity relationships of 7,8-disubstituted-1-cyclopropyl-6-methyl-1,4-dihydro-4-oxo-3-quinoline carboxylic acids].
    Wang H; Qi J; Sun L; Yu L; Guo H
    Yao Xue Xue Bao; 1998 Sep; 33(9):675-81. PubMed ID: 12016871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.